11.10.17

Signet Accel Announces Curt Weber as National Sales Director of Pharma Division

Seasoned executive joins fast-growing healthcare software and services company; charged with leading market development in its pharma division.

COLUMBUS, Ohio--(BUSINESS WIRE)--Software and services company Signet Accel announced today that Curt Weber joined the company as National Sales Director of its pharma division. With more than two decades in healthcare, Weber will expand Signet Accel’s portfolio of national and international biopharma clients and support the executive team in further establishing the brand as a leader in healthcare technology and data integration.

“Signet Accel has the answer, finally, to the question of interoperability and data integration,” Weber said. “Throughout my healthcare career, it has been one of the biggest challenges that my clients have faced. I worked for a large EMR company but ran into roadblocks where disparate data couldn’t connect. I’ve also worked for a data analytics company, and while powerful, the tools are only as effective as the data you put into it. Avec® delivers the solution to ensure both EMRs and analytics tools reach their maximum potential.”

Weber’s extensive experience in HIT and pharma sales includes positions with Cerner, GlaxoSmithKline, RBC Medical Innovations, Morgan-Hunter Healthcare, Inc. and most recently, IBM Watson Health Analytics.

Read the full release on Business Wire.